This morning Senseonics announced that Dr. Francie Kaufman has been appointed Chief Medical Director. Per a company issued press release;
“Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the appointment of Francine R. Kaufman, M.D. as Chief Medical Officer, effective immediately.”
As everyone in the diabetes world knows Dr. Kaufman held the same position at Medtronic until her supposed “retirement” late last year. We have long known that this retirement was just a cover story . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.